AQR Capital Management LLC Buys 54,309 Shares of Oscar Health, Inc. (NYSE:OSCR)

AQR Capital Management LLC raised its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 55.2% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 152,630 shares of the company’s stock after acquiring an additional 54,309 shares during the period. AQR Capital Management LLC owned about 0.06% of Oscar Health worth $2,415,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of OSCR. Symmetry Peak Management LLC bought a new position in shares of Oscar Health in the fourth quarter valued at approximately $488,000. Allspring Global Investments Holdings LLC purchased a new stake in shares of Oscar Health during the 1st quarter valued at $4,117,000. Assenagon Asset Management S.A. raised its stake in shares of Oscar Health by 32.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock worth $32,368,000 after purchasing an additional 507,009 shares during the period. First Light Asset Management LLC purchased a new position in shares of Oscar Health in the 4th quarter worth about $8,854,000. Finally, Gilder Gagnon Howe & Co. LLC grew its position in Oscar Health by 21.0% during the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 2,830,947 shares of the company’s stock valued at $25,903,000 after buying an additional 491,861 shares during the period. 75.70% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have commented on OSCR shares. Piper Sandler reaffirmed an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a research report on Tuesday, September 10th. Wells Fargo & Company upped their price objective on Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research note on Wednesday, June 12th. Finally, UBS Group initiated coverage on Oscar Health in a research report on Monday. They issued a “neutral” rating and a $23.00 target price for the company. Three research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Oscar Health has a consensus rating of “Moderate Buy” and an average price target of $24.00.

Oscar Health Price Performance

Oscar Health stock opened at $18.28 on Wednesday. The firm has a market capitalization of $4.34 billion, a P/E ratio of -45.65, a PEG ratio of 40.11 and a beta of 1.62. Oscar Health, Inc. has a one year low of $4.72 and a one year high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91. The business has a fifty day moving average price of $18.98 and a 200-day moving average price of $18.09.

Oscar Health (NYSE:OSCR) last issued its earnings results on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The business had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.13 billion. During the same quarter last year, the company earned ($0.07) EPS. The firm’s revenue was up 44.6% compared to the same quarter last year. As a group, equities research analysts forecast that Oscar Health, Inc. will post 0.01 EPS for the current year.

Insider Activity at Oscar Health

In other Oscar Health news, CAO Victoria Baltrus sold 4,226 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $76,025.74. Following the sale, the chief accounting officer now directly owns 140,648 shares in the company, valued at $2,530,257.52. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, EVP Alessandrea C. Quane sold 16,793 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $17.06, for a total value of $286,488.58. Following the transaction, the executive vice president now directly owns 392,607 shares in the company, valued at approximately $6,697,875.42. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Victoria Baltrus sold 4,226 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the completion of the sale, the chief accounting officer now directly owns 140,648 shares in the company, valued at $2,530,257.52. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 169,569 shares of company stock valued at $3,007,069. Corporate insiders own 25.11% of the company’s stock.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.